Stock Data
$0.17 (1.03%)
Asset Type
Common Stock
Exchange
NYSE
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
MEDICAL INSTRUMENTS & SUPPLIES
Bausch + Lomb Corporation, headquartered in Vaughan, Canada, is a global leader in eye health. Founded in 1853, it offers a wide range of products across three main segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The company provides everything from contact lenses and eye care products to pharmaceuticals for treating eye conditions like glaucoma and dry eyes, as well as surgical devices and technologies for eye conditions. As a key subsidiary of Bausch Health Companies Inc., Bausch + Lomb is dedicated to addressing the full spectrum of eye health needs.
Bausch & Lomb swung to GAAP operating profit and raised full-year guidance, powered by a 175% surge in premium intraocular lens revenue and 27% growth in its flagship pharmaceuticals MIEBO and XIIDRA. Cash flow from operations more than tripled to $153 million, though adjusted EPS of $0.15 missed consensus by 6.5%.
3 Articles
Our top personal finance-related articles today. Your wallet will thank you later.
